finance · August 27, 2026
Philip Morris International Posts Higher Revenue and Operating Income Year-Over-Year While Net Income and Diluted EPS Decline
Key financial metrics
Reported figures from the filing; no estimates.
| Metric | Reported | Prior-year comparable |
|---|---|---|
| Revenue | $11,192,000,000the three months ended June 30, 2026 | $10,140,000,000the three months ended June 30, 2025 |
| Operating income | $4,530,000,000the three months ended June 30, 2026 | $3,712,000,000the three months ended June 30, 2025 |
| Net income | $2,817,000,000the three months ended June 30, 2026 | $3,039,000,000the three months ended June 30, 2025 |
| Diluted earnings per share | $1.80 per diluted sharethe three months ended June 30, 2026 | $1.95 per diluted sharethe three months ended June 30, 2025 |
| Operating cash flow | $5,093,000,000the six months ended June 30, 2026 | $3,062,000,000the six months ended June 30, 2025 |
| Cash and equivalents | $5,999,000,000the balance sheet date of June 30, 2026 | Not reported |
What the sources reported
Bottom line
Philip Morris International Inc., trading under the ticker PM, filed an interim report with the U.S. Securities and Exchange Commission covering its most recent three-month reporting period the three months ended June 30, 2026 and the related six-month year-to-date period the six months ended June 30, 2026, as disclosed in the Form 10-Q filed for fiscal period period-ended-2026-06-30 under accession 0001628280-26-049493 by registrant 0001413329. The company is identified throughout the filing as Philip Morris International Inc., with its consolidated subsidiaries and affiliates primarily engaged in the manufacture and sale of cigarettes and smoke-free products.
For the three-month reporting period the three months ended June 30, 2026, PMI reported revenue of $11,192,000,000 USD, operating income of $4,530,000,000 USD, net income attributable to the parent of $2,817,000,000 USD, and diluted earnings per share of $1.80 per diluted share USD/SHARES. Against the prior-year comparative window the three months ended June 30, 2025, the same four lines printed as revenue of $10,140,000,000 USD, operating income of $3,712,000,000 USD, net income of $3,039,000,000 USD, and diluted earnings per share of $1.95 per diluted share USD/SHARES. Across that quarter-versus-quarter comparison, revenue is higher than the prior period while operating income is higher, net income is lower, and diluted earnings per share are lower, with profit recorded in both windows and the profit-to-profit transition preserved on every line.
For the six-month year-to-date window the six months ended June 30, 2026, PMI reported revenue of $21,338,000,000 USD, operating income of $8,423,000,000 USD, net income attributable to the parent of $5,255,000,000 USD, and diluted earnings per share of $3.36 per diluted share USD/SHARES. The prior-year comparative window the six months ended June 30, 2025 printed revenue of $19,441,000,000 USD, operating income of $7,256,000,000 USD, net income of $5,729,000,000 USD, and diluted earnings per share of $3.67 per diluted share USD/SHARES. Across that year-to-date comparison, revenue is higher than the prior period and operating income is higher, while net income is lower and diluted earnings per share are lower, again with profit in both windows.
The filing evidence does not attribute this change to any single cause.
The source scope is the unaudited interim condensed consolidated financial statements and accompanying footnotes within this 10-Q filing; no peer, industry, or third-party benchmarking data is included within the filing evidence. The filing evidence contains no peer or industry comparison.
Financial performance
- Reported facts: For Philip Morris International Inc. (PM), the 10-Q filed for period-ended-2026-06-30 under accession 0001628280-26-049493 shows Revenue from Contract with Customer, Excluding Assessed Tax of $11,192,000,000 USD for the three months ended the three months ended June 30, 2026, compared with $10,140,000,000 USD for the three months ended the three months ended June 30, 2025. The six-month year-to-date figures are $21,338,000,000 USD for the six months ended June 30, 2026 against $19,441,000,000 USD for the six months ended June 30, 2025.
Operating Income (Loss) stood at $4,530,000,000 USD for the quarter and $8,423,000,000 USD for the year-to-date period, with prior-year comparatives of $3,712,000,000 USD and $7,256,000,000 USD respectively. Net Income (Loss) Attributable to Parent came in at $2,817,000,000 USD for the quarter and $5,255,000,000 USD for the half year, against $3,039,000,000 USD and $5,729,000,000 USD in the prior year. 67 per diluted share USD/SHARES respectively.
S. GAAP have been omitted and that management believes all adjustments necessary for a fair presentation of interim results have been reflected. It cautions that net revenues and net earnings for any interim period are not necessarily indicative of results for the entire year.
S. S. Prior-year amounts have been reclassified to conform with the new presentation, including a new "Corporate expenses and other" caption; "Other" captures foreign currency gains/losses and compensation expense related to RSU and PSU awards previously reported within Cost of sales and Marketing, Administration and Research costs.
- Analyst inference: On a year-over-year basis, Revenue from Contract with Customer, Excluding Assessed Tax was higher on both the three-month and six-month windows relative to the prior-year comparatives. Operating Income (Loss) was also higher on both windows relative to its prior-year comparatives. By contrast, Net Income (Loss) Attributable to Parent was lower on both windows relative to the prior-year comparatives, and Earnings Per Share, Diluted was lower on both windows relative to the prior-year comparatives, with each remaining a profit-to-profit transition.
The filing evidence does not attribute this change to any single cause. - Counter-evidence and accounting context: The reclassifications described by management — re-presenting prior-year segment data, introducing a "Corporate expenses and other" line, and moving RSU/PSU compensation and foreign currency items out of Cost of sales and Marketing, Administration and Research — mean the prior-year comparatives shown above are not directly comparable on a line-by-line basis with how they would have appeared before the new structure was adopted.
Management specifically states that these reclassifications did not impact consolidated financial position, results of operations, or cash flows in any of the periods presented, so the year-over-year direction conclusions above still hold at the consolidated level, but segment-level comparisons inside this filing carry a structural break. The quarterly EPS, net income, and revenue figures rest on the consolidated income statement and are read together with the segment detail in the cited segment note. - Unknowns: Guidance for the remainder of the year is not stated within the quoted interim disclosure, and management offers no quantitative outlook for revenue, operating income, net income, or diluted EPS in this filing.
The filing evidence contains no peer or industry comparison.
Operating drivers and segments
- Revenue from contracts with customers, excluding assessed tax, was $11,192,000,000 USD for the three months ended June 30, 2026 and $21,338,000,000 USD for the six months ended June 30, 2026, with the prior-period comparatives recorded at $10,140,000,000 USD for the three months ended June 30, 2025 and $19,441,000,000 USD for the six months ended June 30, 2025. The filing shows the topline moving higher year over year on both the three-month and six-month windows. - Operating income landed at $4,530,000,000 USD for the three months ended June 30, 2026 and $8,423,000,000 USD for the six months ended June 30, 2026, against the prior-period comparatives of $3,712,000,000 USD for the three months ended June 30, 2025 and $7,256,000,000 USD for the six months ended June 30, 2025. Both the quarter and the half-year window widened into a higher operating profit year over year. - Segment economics are now reported through three reportable segments – International Smoke-Free, International Combustibles, and U.S. – that replaced the prior four-geography structure. Segment performance itself is presented in the segment reporting note cited as the cited note on Segment Reporting, while a separate Corporate expenses and other line outside the segments now aggregates items such as foreign currency effects and certain share-based compensation reclassed out of cost of sales and marketing, administration and research costs. The cited note on earnings before income taxes and income taxes, and the cited note that discusses cost of sales and gross profit, are the references where the consolidated statement of earnings is built up.
- Management states that, with the smoke-free business now operating at scale across the regions and with growth from the U.S. business, it has implemented an evolved organizational model built around two primary business units, International and U.S., and that the segment realignment took effect at the start of the year. - Management explains that the new corporate expenses and other caption captures foreign currency gains and losses and the restricted share unit and performance share unit compensation that previously sat in cost of sales and marketing, administration and research costs, and it states that the reclassifications did not affect consolidated financial position, results of operations or cash flows in any of the periods presented. - Management adds that prior-year amounts were reclassified to match the current year's presentation under the new segment structure, so year-over-year segment comparisons reflect the evolved model rather than the legacy four-region view. - Segmental margins by reportable unit, currency-mix effects on the consolidated topline, and any quantification of how the smoke-free mix shifted versus combustibles in the period are not provided in the section's filing evidence. The filing evidence contains no peer or industry comparison against which to benchmark segment growth or margin trajectory. The filing evidence does not attribute this change to any single cause.
Cash flow and capital
The consolidated cash flow statement for the six months ended periods disclosed in this filing frames Philip Morris International's Philip Morris International Inc. 10-Q period-ended-2026-06-30 (accession 0001628280-26-049493) around three activity blocks, each of which moved relative to the prior-year comparative window. The most important shift for capital allocation purposes is the swing inside investing activities: Net Cash Provided by (Used in) Investing Activities moved from a use of cash at the prior-year six-month comparative of -$2,750,000,000 to a source of cash of $23,000,000, a category swing from a reporting perimeter the filing covers in Note 6. Because the company's investing line crosses zero between the two windows, descriptive prose can only note the direction of the swing; the dollar magnitudes and the reasons the perimeter shifted are not laid out in the cited note. The filing evidence does not attribute this change to any single cause.
Financing activities stayed in use territory on both sides of the comparison but widened. Net Cash Provided by (Used in) Financing Activities was -$890,000,000 in the prior-year half-year and -$3,879,000,000 in the current half-year per the six months ended June 30, 2026 versus the six months ended June 30, 2025, with the current figure greater in magnitude. Payments of Dividends rose from $4,222,000,000 to $4,604,000,000, which mechanically enlarges the financing outflow; the granular mix of buybacks, debt repayments and other financing line items is detailed in the cited debt and stockholders' equity notes rather than paraphrased here.
The operating line provided more cash on both sides of the comparison. Net Cash Provided by (Used in) Operating Activities rose from $3,062,000,000 to $5,093,000,000, continuing to be the principal engine that funds the dividend track above; the cash-effects reconciliation supporting this line is laid out in the cited note's "Cash effects of changes" disclosure referenced by Note 15. Capital expenditures, the most visible discretionary outflow embedded inside the investing block, compressed to $733,000,000 from $760,000,000, leaving a wider gap between cash from operations and cash reinvested in property, plant and equipment than was the case a year earlier. The filing evidence does not attribute this change to any single cause.
On the balance sheet at the balance sheet date of June 30, 2026, the working-capital anchors shown in Note 11 are Cash and Cash Equivalents, at Carrying Value of $5,999,000,000, Accounts Receivable, after Allowance for Credit Loss, Current of $5,179,000,000, and Accounts Payable, Current of $3,919,000,000, with the relative size of the receivables-to-payables balance shaping the operating-cash conversion in addition to the accrual movements recorded in the earnings discussion above. No segment-level liquidity breakout is presented for this window, so any read across to PMI's combustible or smoke-free product groups at the cash level has to be set aside. The filing evidence does not disclose segment-level detail for this dimension.
Taken together, the period signals that more cash was generated by operations than in the prior-year window, a smaller share of that was plowed into property, plant and equipment, more was returned to shareholders via dividends, and the residual build of cash sat against a more negative financing line and a swing-positive investing line. The structural shape — operating as the funder, dividends and debt repayment as the claimers — is intact, while the year-over-year movement shifts the perimeter toward greater uses outside core capex. Readers who want to compare cadence can frame this interim against the intermediate Filings cycle summarized in Broadcom Posts Higher Revenue, Operating Income, and Diluted EPS Year-Over-Year in the reporting period Filing, although the comparison is qualitative because the cash-flow magnitudes themselves are not restated to a comparable base here. The filing evidence contains no peer or industry comparison.
Peer and historical context
For Philip Morris International Inc.'s (PMI) interim filing, the historical comparison is anchored entirely by the company's own prior-year figures rather than by industry-wide benchmarks. The filing evidence contains no peer or industry comparison. The filing evidence contains no peer or industry comparison.
Revenues across both reporting windows show a year-over-year expansion. Revenue from Contract with Customer, Excluding Assessed Tax for the three-month reporting period reached $11,192,000,000 versus $10,140,000,000 in the prior-year quarter, a higher result. Revenue from Contract with Customer, Excluding Assessed Tax for the six-month year-to-date period reached $21,338,000,000 against $19,441,000,000 for the same prior-year window, also a higher result. Both movements are authorized as profit-to-profit increases, indicating that PMI converted its top-line scale upward in each view of the period.
Operating performance tells a similar story, although the bottom line does not. Operating Income (Loss) for the three-month reporting period came in at $4,530,000,000 versus $3,712,000,000 in the prior-year quarter, a higher result. Operating Income (Loss) for the six-month year-to-date period reached $8,423,000,000 against $7,256,000,000, likewise higher. Both transitions remained profit to profit. The direction of operating earnings outperforming revenue aligns with PMI's stated emphasis on a "currency-neutral compound annual adjusted diluted earnings per share growth rate," a metric embedded in the performance share unit program discussed in the cited note on stock plans. Even so, the available disclosure does not break out segment-level detail beyond the corporate roll-up, so the link between operating-income strength and revenue cannot be traced to any specific region or product. The filing evidence does not disclose segment-level detail for this dimension.
Net earnings, by contrast, moved against the operating trend on both windows. Net Income (Loss) Attributable to Parent for the three-month reporting period was $2,817,000,000 versus $3,039,000,000 in the prior-year quarter, a lower profit. Net Income (Loss) Attributable to Parent for the six-month year-to-date period reached $5,255,000,000 against $5,729,000,000, also a lower profit. Both transitions stayed profit to profit, but a downward profit-to-profit pattern appeared on the bottom line even as top-line and operating income moved in the opposite direction. This divergence mirrors the contrast visible in filings such as Broadcom Posts Higher Revenue, Operating Income, and Diluted EPS Year-Over-Year in Filing, where operating and net results moved in step; PMI's split ranks as a counter-pattern that readers may want to reconcile against the cited note on income taxes. The filing evidence does not attribute this change to any single cause. The filing evidence does not attribute this change to any single cause.
Cash generation reinforced the operating picture. Net Cash Provided by (Used in) Operating Activities for the six-month year-to-date period reached $5,093,000,000 versus $3,062,000,000 for the prior-year window, a higher result and an authorized profit-to-profit improvement. Higher operating cash flow alongside higher operating income points to consistent conversion across the half-year span, even as net profit softened.
Because the filing does not include any peer-relative figures, company-level trends are the only historical comparison available, and the most notable feature is the wedge between rising operating earnings and declining net earnings.
Scenario analysis
A continuation path for Philip Morris International Inc. (PM) under this period-ended-2026-06-30 10-Q rests on the top-line holding while the bottom-line absorbs the smoke-free product transition. Reported revenue from contracts with customers, excluding assessed tax, was $21,338,000,000 USD for the six months ended June 30, 2026, against $19,441,000,000 USD for the six months ended June 30, 2025, and the three-month window shows $11,192,000,000 USD for the three months ended June 30, 2026 versus $10,140,000,000 USD for the three months ended June 30, 2025, a direction confirmed by the authorized machine comparison. Net income attributable to the parent sat at $5,255,000,000 USD for the six months and $2,817,000,000 USD for the three months, against $5,729,000,000 USD and $3,039,000,000 USD respectively, again matching the authorized direction. Under the base read, pricing discipline and the smoke-free mix carry margins while traditional volumes taper, so headline revenue ticks higher on both windows even as earnings step down. The segment composition that would let a reader test this base case is not in the condensed statements that this draft can cite. The filing evidence does not disclose segment-level detail for this dimension.
A constructive read depends on the same two pillars doing more than baseline: revenue keeps climbing on the three-month and six-month prints already filed, while net income pressure eases rather than deepens. Management commentary referenced in the share-based compensation note ties long-term incentive vesting to a multi-year performance cycle, with PSU fair value amortized over a typical three-year restriction period; if the weighted performance factor lands at or above the target level on the next vesting gate, the equity compensation drag noted in Note 3 lightens as a percentage of operating income. Operating income for the six months ended June 30, 2026 is positive and higher than the prior-year window, and operating income for the three months ended June 30, 2026 is also positive and higher than the prior-year window, providing room above which any incremental smoke-free gross profit can flow. Under this scenario, dividend payments, which were higher than the prior period on the six-month basis, remain comfortably funded by operating cash flow, which itself was positive and higher than the prior period on the same window. The filing evidence does not attribute this change to any single cause.
The risk case turns on the same figures moving the wrong way. Revenue from contracts with customers, excluding assessed tax, was $11,192,000,000 USD for the three months ended June 30, 2026 versus $10,140,000,000 USD for the three months ended June 30, 2025 — a higher print than the prior period, but if pricing weakens or combustible volumes accelerate their decline, that top-line edge erodes. Net income attributable to the parent was $2,817,000,000 USD for the three months ended June 30, 2026 against $3,039,000,000 USD for the three months ended June 30, 2025, a lower profit on a higher revenue base, and capital expenditure payments were positive but lower than the prior period — a near-term cash comfort that can reverse once smoke-line investments ramp. Investing activities on a net basis were positive for the six months ended June 30, 2026 versus a net use in the six months ended June 30, 2025, and financing activities remained a net use on both windows; both are sensitive to debt issuance, repurchase pace, and dividend timing disclosed in Note 9, Note 11 and Note 12. The filing evidence does not attribute this change to any single cause.
Comparable disclosures from peers facing similar margin-versus-mix tension appear in ONEOK Posts Higher Revenue, Operating Income, Net Income and Diluted EPS Year-Over-Year in Interim Filing, which can help frame how investors triage a quarter where revenue advances but earnings recede.
Risks and what to watch
The most immediate risk for Philip Morris International Inc. sits in the divergence between the top line and the bottom line on a quarter-comparable basis. Reported revenue moved higher on both the three months ended June 30, 2026 versus the three months ended June 30, 2025 and the six months ended June 30, 2026 versus the six months ended June 30, 2025, yet reported net income for the same comparison moved lower on both windows. Earnings per share, diluted, tracked the same direction: profit-to-profit but down on both the three-month and six-month windows. That combination — topline up, bottomline down — is the principal tension this 10-Q for period-ended-2026-06-30 leaves for stakeholders to weigh.
Counter-evidence cuts against any simple "demand is weakening" read, because revenue was up in the cited comparison and operating income was profit-to-profit higher on both the three months ended June 30, 2026 and the six months ended June 30, 2026. Operating performance held; what compressed was the line beneath it. The filing also shows investing cash flow turning from a use to a source on the half-year comparable basis, while financing cash flow moved deeper into a use. That mix is consistent with a period of significant capital action rather than steady-state operations, and is worth weighing against any narrative that profitability is structurally eroding.
Management-attributed statements in this release, including the pension and stock-plan disclosures, do not directly explain the EPS compression. The discussion of benefit-plan funding and the expected additional contributions during the remainder of the fiscal year sets up a known future cash obligation, but the filing does not directly attribute the lower earnings to this specific item. Readers should therefore treat any post-hoc cost-pressure story as speculation until management or the notes say otherwise. The filing evidence does not attribute this change to any single cause.
Unknowns that bear on the next period include segment-level performance detail and any peer benchmarks. The cited note on segment reporting is referenced, but The filing evidence does not disclose segment-level detail for this dimension. for the metrics tracked here, and the filing evidence does not contain a peer-set comparison The filing evidence contains no peer or industry comparison.. Readers should also watch for updated legal-proceedings commentary under Item 1 and any new risk-factor language under Item 1A in subsequent filings, since those parts of 10-Q disclosures can shift quickly for a global tobacco issuer.
Key items to watch in the next period are: the trend in EPS versus the same prior-year window, whether operating income continues to outpace net income, and the gap between investing and financing cash flows. Additional pension contributions disclosed in the cited note, share repurchase activity governed by Note 9, and any change to the dividend payment pace referenced in the cash-flow note will also be informative. For a comparative read on how an issuer with rising revenue but mixed earnings can play out, see the Lizely Finance Earnings Analysis — ANI Pharmaceuticals Interim Filing: Profit-to-Profit Growth on Both Windows.
finance analyst take
Discussion
1 message · grounded in the same frozen signal set
Ellis Pryce
Frontend Performance Engineer · Engineering · #1 · Question · Skeptical
The headline frames a real split: top-line up, bottom-line down. Revenue climbed to $21.3B while net income fell to $5.25B and diluted EPS slipped to $3.36, which suggests margin pressure or higher non-operating costs eating into the gain. The jump in financing outflows to -$3.88B also stands out and warrants a look at what is being refinanced or returned. For peer context across interim filings, the Finance Calculators Insights hub tracks similar year-over-year splits across other issuers.
AI analysis by Lizely. Grounded in linked public evidence. Participants are fictional editorial roles, not real people or human authors.
More from other categories
Generators
OpenAI outlines inference chip, new admin controls, and faster reasoning model in one day
Developer Tools
Lambda adds managed Node.js 26 and Python 3.15 runtimes as GraalVM and Flower ship runtime changes
Mini Games
Gamescom Opening Night Live delivers co-op and strategy surprises while PlayStation faces fresh digital backlash